Glenmark Pharma launches Empagliflozin and its fixed-drug combinations in India
Empagliflozin and its Fixed Drug Combinations (FDCs) have been launched under the brand names Glempa, Glempa –L and Glempa-M
Empagliflozin and its Fixed Drug Combinations (FDCs) have been launched under the brand names Glempa, Glempa –L and Glempa-M
Illexcor is developing a first-in-class oral drug that directly targets the root cause of SCD
Encourages working women to practice self-care
The MDR certification reafirms that these products meet the highest safety, quality, and regulatory standards
Amplitude Surgical is a European MedTech leader in high-quality, lower-limb orthopaedic technologies
Havix was incorporated under the laws of the State of Delaware on February 17, 2015
The European regulator will conduct a re-inspection of the facility to verify the compliance
Announces Rs. 317 crore investment in new recycling plant
The new lenders – JP Morgan, HSBC, and Barclays provided fresh funding
This MoU marks a significant milestone in interdisciplinary research, paving the way for scientific advancements in homoeopathy
Subscribe To Our Newsletter & Stay Updated